Src-I1 is a potent and competitive dual site (ATP- and peptide-binding) Src kinase inhibitor (IC50s = 44 nM for Src and 88 nM for Lck). Also inhibits VEGFR2 (IC50 = 320 nM).
* VAT and and shipping costs not included. Errors and price changes excepted